Recce Pharmaceuticals Ltd.ASX: RCE

Regulatory Approval for Registrational Phase 3 R327G Trial

Dec 9, 2024 at 3:25 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment